| 臺大學術典藏 |
2021-05-27T09:06:29Z |
Gustatory function and the uremic toxin, phosphate, are modulators of the risk of vascular calcification among patients with chronic kidney disease: A pilot study
|
Chen S.-I.; Chiang C.-L.; Chao C.-T.; CHIH-KANG CHIANG; Huang J.-W. |
| 國立成功大學 |
2023 |
Gut butyrate-producers confer post-infarction cardiac protection
|
Chen, H.-C.;Liu, Y.-W.;Chang, K.-C.;Wu, Y.-W.;Chen, Y.-M.;Chao, Y.-K.;You, M.-Y.;Lundy, D.J.;Lin, C.-J.;Hsieh, M.L.;Cheng, Y.-C.;Prajnamitra, R.P.;Lin, P.-J.;Ruan, S.-C.;Chen, D.H.-K.;Shih, E.S.C.;Chen, K.-W.;Chang, S.-S.;Chang, Chang C.M.C.;Puntney, R.;Moy, A.W.;Cheng, Y.-Y.;Chien, H.-Y.;Lee, J.-J.;Wu, D.-C.;Hwang, M.-J.;Coonen, J.;Hacker, T.A.;Yen, C.-L.E.;Rey, F.E.;Kamp, T.J.;Hsieh, P.C.H. |
| 臺大學術典藏 |
2019 |
Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis
|
Young J.D.; HSIN-CHIH LAI; Lu C.-C.; Ko Y.-F.; Ojcius D.M.; Martel J.; Lin T.-L.; Chang C.-J.; Lin C.-S.; Wu T.-R.; Wu T.-R.;Lin C.-S.;Chang C.-J.;Lin T.-L.;Martel J.;Ko Y.-F.;Ojcius D.M.;Lu C.-C.;Young J.D.;Hsin-Chih Lai |
| 國立成功大學 |
2021-08 |
Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics
|
Hung;Yuan-Pin;Lee;Ching-Chi;Lee;Jen-Chieh;Tsai;Pei-Jane;Ko;Wen-Chien |
| 國家衛生研究院 |
2025-12-26 |
Gut microbes with the gbu genes determine TMAO production from L-carnitine intake and serve as a biomarker for precision nutrition
|
Wu, WK;Lo, YL;Chiu, JY;Hsu, CL;Lo, IH;Panyod, S;Liao, YC;Chiu, THT;Yang, YT;Kuo, HC;Zou, HB;Chen, YH;Chuang, HL;Yen, JJY;Wang, JT;Chiu, HM;Hsu, CC;Kuo, CH;Sheen, LY;Kao, HL;Wu, MS |
| 臺大學術典藏 |
2021-06-15T03:11:47Z |
Gut Microbial Transcytosis Induced by Tumour Necrosis Factor-like 1A-dependent Activation of a Myosin Light Chain Kinase Splice Variant Contributes to Inflammatory Bowel Disease
|
Pai Y.-C.; Weng L.-T.; SHU-CHEN WEI; Wu L.-L.; Shih D.Q.; Targan S.R.; Turner J.R.; Yu L.C.-H. |
| 臺大學術典藏 |
2022-02-15T06:22:45Z |
Gut Microbial Transcytosis Induced by Tumour Necrosis Factor-like 1A-dependent Activation of a Myosin Light Chain Kinase Splice Variant Contributes to Inflammatory Bowel Disease
|
Pai Y.-C.; Weng L.-T.; Wei S.-C.; Wu L.-L.; Shih D.Q.; Targan S.R.; Turner J.R.; LINDA CHIA-HUI YU |
| 國立交通大學 |
2019-04-02T06:00:57Z |
Gut microbiome changes in overweight male adults following bowel preparation
|
Chen, Hui-Mei; Chen, Chung-Chu; Chen, Chien-Chi; Wang, Shen-Chih; Wang, Chun-Lin; Huang, Chien-Hsun; Liou, Jong-Shian; Liu, Ta-Wei; Peng, Hwei-Ling; Lin, Feng-Mao; Liu, Chia-Yuan; Weng, Shun-Long; Cheng, Chieh-Jen; Hung, Yi-Fang; Liao, Chii-Cherng; Huang, Hsien-Da |
| 臺大學術典藏 |
2022-02-18T08:25:51Z |
Gut microbiome in Parkinson's disease: New insights from meta-analysis
|
Toh T.S.; Chong C.W.; Lim S.-Y.; Bowman J.; Cirstea M.; Lin C.-H.; CHIEH-CHANG CHEN; Appel-Cresswell S.; Finlay B.B.; Tan A.H. |
| 臺大學術典藏 |
2022-09-15T02:44:12Z |
Gut microbiome in Parkinson's disease: New insights from meta-analysis
|
Toh T.S.; Chong C.W.; Lim S.-Y.; Bowman J.; Cirstea M.; CHIN-HSIEN LIN; Chen C.-C.; Appel-Cresswell S.; Finlay B.B.; Tan A.H. |
| 臺大學術典藏 |
2019 |
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
|
Chiu H.-Y.; TSEN-FANG TSAI; Hsu C.-Y.; Yeh N.-L.; Yeh N.-L.;Hsu C.-Y.;Tsen-Fang Tsai;Chiu H.-Y. |
| 臺大學術典藏 |
2022-01-11T06:49:28Z |
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
|
Yeh N.-L.; Hsu C.-Y.; Tsai T.-F.; HSIEN-YI CHIU |
| 臺大學術典藏 |
2020-12-28T08:14:07Z |
Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease
|
Yang Y.-J.; YEN-HSUAN NI |
| 國立成功大學 |
2019 |
Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease
|
Yang, Yang Y.-J.;Ni, Y.-H. |
| 國立臺灣大學 |
2015 |
Gut microbiota and the development of pediatric diseases
|
Lu, Chun-Yi; Ni, Yen-Hsuan; 呂俊毅; 倪衍玄 |
| 臺大學術典藏 |
2020-12-28T08:14:19Z |
Gut microbiota and the development of pediatric diseases
|
Lu C.-Y.; YEN-HSUAN NI |
| 臺大學術典藏 |
2015 |
Gut microbiota and the development of pediatric diseases
|
Ni Y.-H.; CHUN-YI LU |
| 臺大學術典藏 |
2020-07-03T04:00:27Z |
Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: Discovery and validation study
|
Hsieh W.-P.; Chung W.-H.; HSIN-CHIH LAI; Su S.-C.; Wu I.-W.;Lin C.-Y.;Chang L.-C.;Lee C.-C.;Chiu C.-Y.;Hsu H.-J.;Sun C.-Y.;Chen Y.-C.;Kuo Y.-L.;Yang C.-W.;Gao S.-S.;Hsieh W.-P.;Chung W.-H.;Hsin-Chih Lai;Su S.-C.; Wu I.-W.; Lin C.-Y.; Chang L.-C.; Lee C.-C.; Chiu C.-Y.; Hsu H.-J.; Sun C.-Y.; Chen Y.-C.; Kuo Y.-L.; Yang C.-W.; Gao S.-S. |
| 國家衛生研究院 |
2023-01-11 |
Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes
|
Huang, HL;Luo, YC;Lu, PL;Huang, CH;Lin, KD;Lee, MR;Cheng, MH;Yeh, YT;Kao, CY;Wang, JY;Yang, JM;Chong, IW |
| 國家衛生研究院 |
2022-08-22 |
Gut microbiota in kawasaki disease
|
Huang, CH;Yeh, YT |
| 臺大學術典藏 |
2021-12-24T02:25:53Z |
Gut microbiota in the innate immunity against hepatitis B virus - implication in age-dependent HBV clearance
|
Wu, Li-Ling; Huang, Ting-Shuo; Shyu, Yu-Chiau; Wang, Chih-Lin; Wang, Hurng-Yi; Chen, Pei-Jer |
| 臺大學術典藏 |
2021-08-15T00:08:29Z |
Gut microbiota in the innate immunity against hepatitis B virus — implication in age-dependent HBV clearance
|
Wu, Li Ling; Huang, Ting Shuo; Shyu, Yu Chiau; Wang, Chih Lin; HURNG-YI WANG; PEI-JER CHEN |
| 臺大學術典藏 |
2021-11-15T07:05:06Z |
Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide
|
HSIN-CHIH LAI; Lin, Tzu-Lung; Chen, Ting-Wen; Kuo, Yu-Lun; Chang, Chih-Jung; Wu, Tsung-Ru; Shu, Ching-Chung; Tsai, Ying-Huang; Swift, Simon; Lu, Chia-Chen |
| 國立成功大學 |
2023-10 |
Gut microbiota of Pacific white shrimp (Litopenaeus vannamei) exhibits distinct responses to pathogenic and non-pathogenic Vibrio parahaemolyticus
|
Chang;Yi-Ting;Ko;Hao-Ting;Wu;Ping-Lun;Kumar;Ramya;Wang;Han-Ching;Lu;Hsiao-Pei |
| 國家衛生研究院 |
2021-09-10 |
Gut microbiota-modulated metabolomic profiling shapes the etiology and pathogenesis of autoimmune diseases
|
Tsai, YW;Dong, JL;Jian, YJ;Fu, SH;Chien, MW;Liu, YW;Hsu, CY;Sytwu, HK |
